Metabolon vs. Stemina Biomarkers Patents can be Considered as True Inventions?
Posted in the Genetics Forum
#1 Oct 15, 2012
This blog critically analyzes the limitations and pitfalls in biomarker patent process. According to the argument made in this blog, most of the biomarkers patents may not have commercial prospective, though patents are intend to protect the right to manufacture and sell invented products, due to the fact that these biomarkers were identified and characterized without following solid scientific principles and demonstrating clinical applications, which are indispensable for developing commercially viable products. Claimed inventions proposed in patents without adequate scientific research driven supporting evidences and reasonable interpretation of experimental results, as oppose to peer reviewed scientific publications, may not have any scientific value or may not be scientifically acceptable. These patents can also be scientifically mistaken and these patents may not only preclude innovation in biomarker discovery but also hinder the development of low-cost patient care diagnostics products. Read more: http://www.sciclips.com/sciclips/blogArticle....
Add your comments below
|The Circadian Rhythm Gene Arntl2 Is a Metastasi...||18 hr||Stephany McDowell||2|
|Can Crispr-Cas9 Boost Intelligence?||Sat||Stephany McDowell||1|
|Different Tree Species Use the Same Genes to Ad...||Sep 23||Stephany McDowell||1|
|Common cancers share familial susceptibility: i...||Sep 23||Stephany McDowell||1|
|Mediterranean Diet Can Lower Risk for Alzheimer...||Sep 23||Stephany McDowell||1|
|A better theory of intelligent design||Sep 23||Chazofsaints||21|
|Autism risk in younger children increases if th...||Sep 22||friend||5|
Find what you want!
Search Genetics Forum Now
Copyright © 2016 Topix LLC